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Objective: To evaluate prevalence of and risk factors for hepati- 
tis C virus (HCV) infection and the role of genital ulcer disease 
in the sexual transmission of HCV among 1280 nonintravenous- 
drug-using heterosexuals attending a sexually transmitted dis- 
ease clinic. 
Methods: Serum samples were tested by a third-generation 
enzyme-linked immunosorbent assay (ELISA) test. Reactive 
sera were confirmed using a RIBA assay. The independent 
effect of different variables on the likelihood to be anti-HCV 
positive was assessed by multiple logistic regression analysis. 
Results: The overall anti-HCV prevalence was 4.9%, a rate 
nearly ten times as high as the 0.5% recently found in a national 
sample of young male adults 18 to 26 years old. The preva- 
lence was 9.6% in subjects with positive syphilis serology and 
3.8% in those without a history of sexually transmitted disease. 
Multiple logistic regression analysis showed that age greater 
than 34 years (OR 2.9; 95% Cl 1 .l-7.6), low educational level 
(OR 2.0; 95% Cl 1 .I-3.5), positive syphilis serology (OR 2.1; 
95% Cl 1.04-4.1), and anti-HIV positivity (OR 4.6; 95% Cl 
1.2-I 8.7) were all independent predictors of HCV infection. 
Conclusions: These findings are consistent with sexual trans- 
mission of HCV. Syphilis infection may be a cofactor in HCV 
transmission or, alternatively, may be a strong indicator of high- 
risk sexual behavior. 
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Hepatitis C virus (HCV) is the cause of most parenterally 
transmitted non-A, non-B hepatitis.Transmission by blood 
transfusion, intravenous drug use, surgical intervention, 
and occupational exposure is well documented, whereas 
the risk of sexual transmission is not well defined. 
High anti-HCV prevalence has been reported in 
patients with sexually transmitted diseases (STDS),‘-~ in 
homosexuals with multiple sexual partners,*s5 and in 
spouses of patients with type C chronic liver disease.6 In 
contrast, little or no transmission of HCV was found in 
sexual partners of HCV infected hemophiliacs.7,s A study 
on acute non-A, non-B anti-HCV positive hepatitis in the 
United States showed an association with multiple sex- 
ual partners9 whereas a weak and not significant asso- 
ciation was found in a similar study done in Italy. lo 
Genital ulcers or erosions have been shown to be 
cofactors for hepatitis B virus (HBV) transmission,3~11~12 
but little information is available on the role of these fac- 
tors for HCV transmission. 
The aim of the present study, which used a sensitive 
third-generation test for HCV antibody, was to evaluate the 
prevalence of and risk factors for HCV infection among 
heterosexuals attending a clinic for sexually transmitted 
diseases in Rome, who denied blood transfusion and intra- 
venous drug use. Particular attention was paid to the role 
of genital ulcerative diseases. 
METHODS 
Study Population 
The study was conducted at the STD outpatient clinic of 
the S. Maria e S. GaIlicano hospital in Rome, from February 
to December 1989 and from January 1993 to April 1994, 
as part of a study of human immunodeficiency virus (HIV) 
seroprevalence. Homosexual or bisexual men, intravenous 
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drug users, and blood transfused patients were excluded 
from the study. 
During the first period, all the patients seen at the 
STD clinic were enrolled in the study; in the second 
period, all the patients reporting genital ulcers or ero- 
sions, and, on a random day a week, all the patients attend- 
ing the clinic were recruitedAfter informed consent was 
obtained, the patients provided a blood sample and were 
administered an anonymous questionnaire, by a trained 
interviewer, to assess basic sociodemographic informa- 
tion (age, sex, education), sexual preference, number of 
sexual partners and condom usage in the year before the 
visit, history of intravenous drug use, blood transfusion, 
and history of STDs. Ulcerative diseases included syphilis 
and genital herpes infection. Non-ulcerative STDs 
included gonorrhea, genital warts, nongonococcal ure- 
thritis due to Chlamydia trachomatis or Ureaplasma 
urealyticum, vaginal or cervical infection due to Tri- 
chomonas vaginalis, Candida albicans, or Chlamydia, 
scabies, and Phthirus pubis infestation. 
Laboratory Methods 
The serum samples collected in both study periods were 
stored at -20°C until tests were performed. All samples 
were tested with the third-generation Ortho HCV 3.0 
enzyme-linked immunosorbent assay (ELISA) (Ortho Diag- 
nostic Systems, Raritan, New Jersey). Reactive sera were 
also tested with an additional, more specific assay (Chi- 
ron RIBA HCV 3.0 SL4, Ortho Diagnostic Systems) con- 
sisting of a qualitative immunoblot assay that utilizes HCV 
antigens, immobilized as individual bands onto test strips. 
The two recombinant antigens (c33c and NS5) and two 
of the synthetic peptides (~100~ and 5-1-1~) are derived 
from putative nonstructural regions of the virus, whereas 
the third peptide (~22~) corresponds to the putative 
nucleocapsid (core) viral protein. Sera were confirmed 
as positive when at least two HCV bands were reactive. 
Syphilis serologic testing was performed with the 
rapid plasma reagin screening test and the hemaggluti- 
nation test for Treponema pallidurn and an enzyme 
immunoassay test for IgM and IgG for confirmation. Dark- 
field microscopy was performed on any lesion or rash 
compatible with primary or secondary syphilis. 
The diagnosis of genital herpes was clinical. Serologic 
testing for chlamydial infection was made by ELISA.Vagi- 
nal and urethral specimens were either examined by 
Gram stain or cultured for Neisseria gonorrhoeae. 
Statistical Analysis 
Differences between proportions were tested by chi- 
square and Fisher’s exact test, where appropriate. The 
strength of association of each considered variable with 
anti-HCV positivity was estimated by calculating crude 
odds ratios (OR) by univariate ana1ysis.A logistic regres- 
sion model was used to identify variables independently 
associated with anti-HCV positivity. Only variables sig- 
nificantly associated with anti-HCV positivity in the uni- 
variate analysis were entered into the model. For each 
variable the reference category was the most favorable 
level of exposure (youngest age, female sex, highest edu- 
cation level, lowest number of sexual partners, use of 
condoms, negative history of STDs). Because of a strong 
correlation between reactive syphilis serology and anti- 
HBc, for the purpose of assessing the strength of associ- 
ation between HCV infection and serologic results 
positive for syphilis, this last variable was not included in 
the model. BMDP Statistical Software 1990 (Berkeley, CA) 
was used for all calculations.13 
RESULTS 
A total of 1771 patients were asked to participate in the 
study (1090 in 1989 and 681 in 1993-1994). Of these, 975 
(89.4%) in the first period and 522 (76.7%) in the second 
period were enrolled.The patients who accepted were 
similar to those who refused with regard to sex, age, num- 
ber of sexual partners in the year previous to the clini- 
cal visit, and history of STDs. 
A total of 782 (80%) of 975 patients who provided a 
blood sample in the first period and 498 (95%) of 522 
in the second period were tested for anti-HCV The 
median age of the 1280 study subjects was 32 years 
(range, 15-78 y).The general characteristics of the two 
groups of patients included in the study are shown in 
Table 1 .The two groups were similar with respect to sex, 
age, number of sexual partners in the previous year, and 
history of STDs.The 1993-1994 group had a higher level 
of education and reported more frequent use of condoms 
as compared with the 1989 group. Of 141 patients with 
genital herpes, 119 (84%) had current disease at the time 
of enrollment into the study, and 22 (16%) reported a 
past history of genital herpesThe overall anti-HCV preva- 
lence was 4.9%. The anti-HCV prevalence was 6.0% in 
1989 and 3.2% in 1993-1994 (P = 0.03)After control- 
ling for education level and diagnosis, this difference still 
remained (P = 0.05). 
The prevalence was 9.6% in patients with positive 
syphilis serology and 3.8% in those without a history of 
STDs (OR 2.8, 95% CI 1.3-5.4)Three of 12 (25%) HIV- 
positive patients were anti-HCV positive versus 59 of 
1246 (4.7%) anti-HIV negative (P = O.OOl).Among I61 
patients who tested positive for syphilis, four (2.5%) were 
also anti-HIV positive. Of these, two (50%) were also anti- 
HCV positive, whereas 14 of 157 (8.9%) HIV negative had 
anti-HCV antibodies (P = 0.05). 
By univariate analysis, a statistically significant asso- 
ciation was found between anti-HCV positivity and age 
greater than 24 years, less than 8 years of education, anti- 
HBc positivity, anti-HIV positivity, and positive syphilis 
serology.Three or more sexual partners in the previous 
year, history of non-ulcerative STD, and present or past 
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Table 1. General Characteristics of Nonintravenous-Drug-Using Heterosexuals Attending a Clinic for Sexually Transmitted Diseases in 
Rome, Italy 
Study Year 
Characteristics 
Sex 
Female 
Male 
Age 
1989 1994 
n = 782 (%) n = 498 (%) P 
209 (27) 148 (30) 0.245 
573 (73) 350 (70) 
15-24 
25-34 
235 
Years of education 
>8 
58 
Number of partners in previous year 
O-2 
23 
Use of condom in previous year 
Yes 
No 
Anti-HIV 
Negative 
Positive 
Anti-HBc 
Negative 
Positive 
Anti-HCV 
Negative 
Positive 
Diagnosis 
No history of STD 
History of non-ulcerative STD 
Current genital herpes 
History of genital herpes 
Primary syphilis 
Secondary syphilis 
Latent syphilis 
166 (21) 99 (20) 
278 (36) 186 (37) 0.758 
338 (43) 213 (43) 
362 (47) 291 (59) 0.000 
414 (53) 206 (41) 
531 (68) 355 (71) 0.194 
250 (32) 142 (29) 
156 (21) 141 (28) 0.002 
604 (79) 357 (72) 
758 (99) 488 (99) 0.860 
7 (1) 5 (1) 
591 (76) 405 (82) 0.011 
185 (24) 88 (18) 
735 (94) 482 (97) 0.024 
47 (6) 16 (3) 
362 (46) 238 (50) 0.000 
248 (32) 103 (22) 
36 (5) 83 (17) 
14 (2) 8 (2) 
4 (0.5) 2 (0.4) 
5 (0.6) 4 (0.8) 
113 (14) 38 (8) 
history of genital herpes were not associated with anti- 
HCV positivity (Table 2). 
Adjustment of each variable for the confounding 
effect of the other variables was done by multivariate 
analysis. The logistic regression model included all the 
variables found significantly associated by univariate 
analysis. Increasing age, low education level, positive 
syphilis serology, and anti-HIV positivity were all inde- 
pendent predictors of HCV infection (Table 3). The 
adjusted odds ratios for positive syphilis serology and 
HIV positivity were 2.1 (95% CI 1.04-4.14) and 4.75 
(95% CI 1.21-18.7) respective1y.A second logistic model 
including a term for interaction between HIV and syphilis 
positivity was run.The estimated odds ratio for the inter- 
action was 4.6 (95% CI 0.23-92.3). 
DISCUSSION 
In this investigation, an overall anti-HCV prevalence of 
4.9% was found in heterosexual patients in a clinic for 
STDs who denied intravenous drug use and blood trans- 
fusion.This rate is nearly ten times as high as the 0.5% 
found in a national sample of young adult males aged 18 
to 26 years tested in 199O,l* and even higher than the 
prevalence found in 1995 among Roman blood donors 
aged 18 to 60 years, which was 0.26% for donors at their 
first donation, and 0.015% for habitual donors tested with 
a third-generation test (Solinas S. Unpublished data). 
The authors evaluated the evidence for sexual trans- 
mission of HCV by estimating the association between 
anti-HCV positivity and other diseases for which the 
sexual route of transmission is well known. In addition, 
the role of potential cofactors for sexual transmission 
of HCV was assessed by estimating the association 
between anti-HCV and STDs causing genital ulcers.The 
most striking finding of this study was the independent 
association linking positive syphilis serology with anti- 
HCV positivity. 
This study confirms the results ofThomas et al3 who 
reported a more than twofold increased risk of HCV infec- 
tions in nonintravenous-drug-using male patients with 
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Table 2. Prevalence of Anti-HCV Positivity among 1280 Nonintravenous-Drug-Using Heterosexuals Attending a Clinic for Sexually 
Transmitted Diseases in Rome, by Sociodemographic Characteristics of Subjects and Potential Risk Factors 
Characteristics 
No. Positive/No. Tested 
f%J OR 95% CI 
Sex 
Female 
Male 
15-24 
25-34 
235 
Years of education 
28 
58 
Number of partners in previous year 
o-2 
23 
Use of condom in previous year 
Yes 
No 
Anti-HIV 
Negative 
Positive 
Anti-HBc 
Negative 
Positive 
18/357 (5.0) 1 
45/923 (4.9) 1.0 0.5-l .8 
5/265 (1.9) 
22/464 (4.7) 
36/551 (6.5) 
21/653 (3.2) 
42/620 (6.8) 
2.6 0.9-8.9 
3.6 1.4-12 
1 
2.2 1.2-3.9 
40/886 (4.5) 1 
23/392 (5.9) 1.3 0.8-2.3 
12/297 (4.0) 1 
48/961 (5.0) 1.3 0.6-2.5 
59/l 246 (4.7) 1 
3/l 2 (25.0) 6.7 1 .I-28 
271996 (2.7) 1 
36/273 (13.2) 5.5 3.2-9.5 
Diagnosis 
No history of STD 23/600 (3.8) 1 
History of non-ulcerative STD 17/351 (4.8) 1.3 0.6-2.5 
Genital herpes 7/l 41 (5.0) 1.3 0.5-3.2 
Positive syphilis serology 16/l 66 (9.6) 2.8 1.3-5.4 
OR = odds ratio derived by univariate analysis: Cl = confidence interval. 
positive syphilis serology, and those of Nakashima and 
colleagues2 who found a significantly higher prevalence 
of HCV in patients with STDs who reported a history of 
at least one episode of syphilis. 
Table 3. Variables Associated with Anti-HCV Positivity among 
1280 Nonintravenous-Drug-Using Heterosexuals Attending a Clinic 
for Sexually Transmitted Diseases in Rome 
Variables 
Age 
15-24 
25-34 
235 
Years of education 
>8 
58 
Anti-HIV 
Negative 
Positive 
Diagnosis 
No history of STD 
OR 95% CI 
1 
2.4 0.9-6.5 
2.9 1 .l-7.6 
1 
2.0 1 .l-3.5 
1 
4.8 1.2-19 
1 
History oi non-ulcerative STD 1.2 0.6-2.3 
Genital herpes 1.2 0.5-2.9 
Positive syphilis serology 2.1 1.04-4.1 
OR = odds ratio derived by multiple logistic regression model. Each variable is 
adjusted for the confounding effect of all others listed in the table. 
Cl = confidence interval. 
Several studies on sexual transmission of HBV have 
already shown an association between syphilis and HBV 
infection3J2J5 Syphilis may be a risk factor even for HCV 
infection for several reasons. First, syphilis can be regarded 
as an indicator of high-risk sexual behavior. Second, it 
may be a cofactor in sexual transmission of HCV; as the 
disruption of the epithelial surface resulting in a genital 
ulcer may in fact facilitate virus transmission. 
The hypothesis of a synergy between HIV and 
syphilis in the transmission of HCV infection was 
explored by running a multiple logistic model that 
included a term for interaction.The odds ratio for inter- 
action of 4.6 was high, but, because of the low statistical 
power due to the small number of subjects positive for 
both HIV and syphilis, its estimate was imprecise, as 
indicated by the wide confidence interval, and not sta- 
tistically significant. 
Association of HCV infection with present or past 
history of genital herpes, which also causes genital ulcer- 
ation, was not found. These results are consistent with 
those of other authors.3 Moreover, even HBV has not been 
found to be associated with genital herpes.3J2 It is spec- 
ulated that some biologic factors linked to the genital 
herpes infection may not facilitate the transmission of 
other sexually transmitted viruses. For example, the 
painful herpetic lesion may be a deterrent from sexual 
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activity. Alternatively, genital herpes could merely be a 
less indicative surrogate marker of high-risk sexual behav- 
ior than syphilisThe authors did not use serology for the 
diagnosis of genital herpes because of the weak correla- 
tion between a positive test and clinical disease. In addi- 
tion, the residual cross-reactivity between herpes simplex 
virus (HSV)-2 and HSV-1 excludes its use for diagnosis in 
absence of symptoms. 
High prevalence of anti-HCV was found in anti-HBc- 
positive subjects, and, although only 12 of 1280 (0.9%) sub- 
jects were anti-HIV positive, as many as 25% of these had 
anti-HCV antibodies.These fmdings suggest common routes 
of transmission of the three viruses. In addition, the strong 
association between HCV and HIV infection, reported in 
several studies, supports the hypothesis that HCV trans- 
mission is more efficient when HIV is present3,*z7 
Behavioral factors, such as multiple sexual partners, 
have been shown to increase sexual transmission of 
HBV9J1~12J6 In the present study, no association was found 
between HCV infection and having three or more sexual 
partners in the year before the visit; this observation con- 
firms the results reported by Weinstock and co-workers.” 
In contrast,Thomas found an increased risk of HCV infec- 
tion for patients reporting more than 24 lifetime sexual 
partners. l8 However, because of the striking differences 
in the definition of the exposure levels used in the vari- 
ous studies, regarding the number of sexual partners, a 
comparison of these results is difficult. 
Age greater than 24 years and having less than 8 years 
of education were also independent risk factors for HCV 
infection. Low education level is a good indicator of low 
socioeconomic status, which is not a risk factor by itself, 
but may identify lifestyles and behaviors that increase the 
likelihood of HCV infection. 
The lack of association between HCV infection and 
the use of condoms and multiple sexual partners could 
be due to the fact that information on these variables 
was collected only for the year prior to the clinic visit; 
hence, the data may not reflect past unprotected sexual 
activity when HCV infection may have been acquired. 
In conclusion, the higher than expected prevalence 
of HCV and its association with syphilis suggest sexual 
transmission of the virusThe association with a positive 
syphilis serology may indicate syphilis as a cofactor in 
the transmission of HCV or, alternatively, as a powerful 
indicator of high-risk sexual behavior. 
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